Instruments of Progress: A Mass Spectrometry Upgrade

Cancer cell biology

Thanks to Pelotonia funds the Proteomics Shared Resource (SR) is welcoming new additions to their mass-spectrometer family. The Proteomics SR is part of the Campus Chemical Instrument Center and managed by Ohio State’s Office of Research and the OSUCCC – James. It provides critical technology and expertise for OSUCCC – James researchers and for cancer research community across Ohio. Mass-spectrometers are essential to the SR for understanding cancer-cell biology. The Orbitrap Fusion™ and Quantiva mass spectrometers are among the new equipment purchased. The purchase is a major upgrade for OSU’s mass spectrometry and proteomics capabilities. The new instruments are housed in the Campus Chemical Instrument Center, which was founded in 1981 to provide research facilities for the entire campus.

 “The Center is an interdisciplinary unit serving faculty from the colleges of Arts and Sciences; Education and Human Ecology; Engineering; Food, Agricultural and Environmental Sciences; Medicine; Optometry; Pharmacy; Veterinary Medicine; and Ohio State’s Comprehensive Cancer Center, to name a few,” says Vicki Wysocki, PhD, an Ohio Eminent Scholar in the Department of Chemistry and Biochemistry in Ohio State’s College of Arts and Sciences, and senior faculty adviser to the Proteomics SR.

Proteomics SR Director Michael Freitas, PhD, an associate professor in the Department of Molecular Virology, Immunology and Medical Genetics at Ohio State and a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, believes the sophisticated new mass spectrometers will enable researchers to identify compounds faster, more accurately and more thoroughly.